scorecardresearch
Saturday, November 2, 2024
TopicPharmaceutical industry

Topic: Pharmaceutical industry

Modi govt’s Rs 7,000-cr scheme to reduce API dependence on China could roll out this month

The criteria for selection of domestic manufacturers for APIs could include 'higher production capacities' and usage of latest technologies that are less polluting.

Why AstraZeneca is pondering a $240 billion gamble with Gilead

Combining the science teams of two pharma giants ought to aid future drug discovery. But it's still not clear if either side needs this deal.

Why India saw only 4 pharma products launched in April, its lowest count ever

The pharma industry has seen a fall of about 99% in new product launches since April 2019, when 349 products were launched.

US drug regulator approves use of diabetes drug, also sold in India, to prevent heart attack

The drug Farxiga is sold in India by UK-based pharma giant AstraZeneca under the brand name ‘Forxiga’ to treat type 2 diabetes.

How India can be a world leader in making Covid vaccine and keeping it cheap too

With a system of mass manufacturing already in place, India is set to play a major role in producing the Covid-19 vaccine and selling it at affordable price across the globe.

Can India balance its domestic pharma needs and also be a global player in Covid-19 fight?

India has lifted the ban on the export of 24 pharmaceutical ingredients, including anti-malaria drug hydroxychloroquine.

India and US must join hands during Covid-19 crisis, not increase nativist impulses

Katherine B. Hadda, former US consul general, Hyderabad, writes on the need for the US and India to unite during the Covid-19 crisis.

US FDA orders removal of ranitidine drugs from market over ‘carcinogen contamination’

Ranitidine is available in India under brand names of Aciloc and Zinetac but FDA specifically names Sanofi’s Zantac.

Govt gives Rs 15,000-cr boost to API and devices industry to check shortage amid COVID-19

The government hasn’t yet announced details of the policy, which seeks to make India self-reliant in the manufacturing of bulk drugs.   

India could ‘withdraw’ curbs on drug exports as pharma firms fear loss of business

In a meeting with govt officials, drug-makers flagged concerns that their clients may start buying products from other countries if restrictions on Indian products continued.

On Camera

As a Hindu Canadian, I am deeply hurt by cancellation of Diwali. My community is now sidelined

Canada faces serious foreign interference issues, but these challenges must not be weaponized to unfairly target friendly and important allies like India.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

Indian firms sanctioned by US didn’t violate laws, says MEA. Hyderabad firm that supplied to Army on list

Among 19 Indian firms sanctioned by US Treasury Dept was Lokesh Machines Ltd accused of coordinating with 'Russian defence procurement agent to import Italy-origin CNC machines'.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.